Latest News

Cardinal Energy Ltd. has released its full-year 2025 results, showing revenue of C$439.04 million and net income of C$20.8 million, while confirming its March cash dividend of C$0.06 per share for payment on April 15, 2026. Amid lower earnings, the company highlighted record fourth-quarter production driven by the Reford SAGD project and continued investment in thermal growth, supported by a recent C$104.7 million equity financing. We will now examine how the Reford SAGD project’s ramp-up...

Recently, NewMarket Corporation has come under pressure as its core petroleum additives business faces structural oversupply, with global capacity additions outstripping demand and intensifying competition from Chinese exporters. An additional concern for investors is that bearish research has highlighted how NewMarket’s heavy reliance on this challenged segment could weigh on overall profitability despite past diversification efforts. Against this backdrop, we’ll explore how persistent...

VinFast Auto (NasdaqGS:VFS) has just posted another loss making quarter, with Q3 FY 2025 revenue of about ₫18.1 trillion and basic EPS of a loss of ₫10,238.74, set against a trailing twelve month revenue base of roughly ₫67.5 trillion and a cumulative loss of about ₫92.5 trillion. Over recent periods the company has seen quarterly revenue move from about ₫8.7 trillion in Q2 FY 2024 to ₫12.3 trillion in Q3 FY 2024, ₫16.3 trillion in Q1 FY 2025 and now ₫18.1 trillion in Q3 FY 2025, while...

WuXi Biologics (Cayman) (SEHK:2269) is back in focus after two recent developments: a collaboration with Earendil Labs on complex antibody and ADC programs, and a record showing at the 2026 Asia Pacific Biopharma Excellence Awards. See our latest analysis for WuXi Biologics (Cayman). Those Earendil and awards announcements arrive as momentum has been mixed, with a 12.85% 1 month share price return decline, a 90 day share price return of 8.73%, and a 1 year total shareholder return of...

Latest FY 2025 Earnings Snapshot WaterBridge Infrastructure (WBI) just posted its FY 2025 numbers with third quarter revenue of US$123.25 million and a basic EPS loss of US$0.02, while net income excluding extra items was a loss of US$0.67 million. The company has seen revenue move from US$89.80 million in the third quarter of 2024 to US$123.25 million in the same period of 2025. The trailing twelve month revenue figure in the dataset stands at US$733.30 million with a net loss of US$91.25...

Earlier this month, The Toro Company reported first-quarter fiscal 2026 results showing sales of US$1,036.3 million and net income of US$67.9 million, and management raised full-year 2026 net sales growth guidance to a range of 3% to 6.5%. Management attributed the stronger performance and confidence in higher guidance to robust demand for snow and ice products, contributions from recent acquisitions, and progress on cost-saving initiatives such as the AMP productivity program. Next, we’ll...

In March 2026, Par Pacific Holdings attracted increased attention as Barclays PLC raised its stake by almost one-quarter, while multiple brokerage firms maintained an “Outperform” consensus rating on the company. This combination of higher institutional ownership and supportive analyst views highlights growing institutional engagement with Par Pacific’s refining and fuel distribution footprint in Hawaii and the Rocky Mountain region. We’ll now explore how rising institutional ownership,...

Why Telstra Group’s ongoing buy-back matters now Telstra Group (ASX:TLS) has updated the market on its ongoing on-market share buy-back, reporting a cumulative 138,864,731 shares repurchased, including 1,951,316 shares on the latest trading day. This continued capital return shapes Telstra Group’s share count, affects per share metrics, and gives you another factor to weigh alongside earnings, dividends and the current A$5.24 share price. See our latest analysis for Telstra Group. The...

Keio (TSE:9008) has just wrapped up a share repurchase program and completed a ¥9,999.75 million buyback, while also issuing ¥10 billion in unsecured green bonds with a fixed 1.537% coupon. See our latest analysis for Keio. Keio's latest ¥3,887 share price comes after a 1 day share price return of 0.67%. However, the 30 day share price return of a 4.64% decline and the 5 year total shareholder return of a 45.55% loss suggest longer term momentum has been weak, even as the recent buyback and...

Fuso ChemicalLtd (TSE:4368) has drawn fresh attention after a 13 March 2026 board meeting to review a manufacturing facility plan for its Kyoto Plant, raising questions about future capacity and capital allocation. See our latest analysis for Fuso ChemicalLtd. At a share price of ¥9,240.0, Fuso ChemicalLtd has seen firm momentum recently, with a 1 day share price return of 3.94% and a 90 day share price return of 46.90%. The 1 year total shareholder return of 161.92% points to strong longer...

Director Estienne de Klerk’s on market purchase of an additional 65,000 Growthpoint Properties Australia (ASX:GOZ) stapled securities, lifting his holding to 1,940,457, has put insider alignment and governance firmly in focus for investors. See our latest analysis for Growthpoint Properties Australia. At a share price of A$2.14, Growthpoint’s 1 month share price return of 3.6% and 3 month share price return of 12.65% sit against a 1 year total shareholder return of 0.73%. This suggests recent...

How Aalberts Stock Has Been Performing Recently Aalberts (ENXTAM:AALB) has moved lower in the very short term, with a 1 day decline of about 1% and a 7 day decline of about 1.4%, drawing fresh attention from investors. Over the past month the share price shows a decline of about 10%. Over the past 3 months it shows a gain of roughly 11%, offering a mixed picture for recent traders and for longer holding periods. See our latest analysis for Aalberts. With the share price at €31.42, Aalberts...

China Tobacco International (HK) (SEHK:6055) has caught investor attention after reporting full year 2025 results, alongside a proposed final cash dividend of HK$0.33 per share, pairing earnings information with a fresh income timeline. See our latest analysis for China Tobacco International (HK). The latest earnings and dividend news comes after a mixed price pattern, with a 1-day share price return of 1.41% against a 30-day share price return decline of 15.29%, yet a 1-year total...

RB Global (RBA) has put a new US$500 million share repurchase plan on the table, targeting up to 10,000,000 shares. The move immediately shifts attention to capital allocation and shareholder returns. See our latest analysis for RB Global. The buyback news comes after a softer period for the shares, with a 7 day share price return of 6.72% and a 90 day share price return of 5.29%. In contrast, the 3 year total shareholder return of 99.05% and 5 year total shareholder return of 91.35% indicate...

Quaker Chemical (KWR) has been drawing attention after a period of weaker share performance, with the stock down about 34% over the past month and 14% over the past 3 months. See our latest analysis for Quaker Chemical. Looking beyond the recent slump, Quaker Chemical’s 30-day share price return of 33.95% and year to date share price return of 14.76% contrast with a 1-year total shareholder return of 4.99% and a 5-year total shareholder return of 48.90%. This suggests that shorter term...

InnoCare Pharma recently dosed the first healthy volunteer in a China clinical trial of ICP-538, an oral VAV1-directed molecular glue degrader for autoimmune diseases, marking the first VAV1 degrader to reach trials in China and only the second globally. This move positions InnoCare at the forefront of a new class of targeted immunology drugs, in an area where no VAV1-focused therapies are yet approved worldwide. We’ll now examine how advancing ICP-538, a first-in-China VAV1 degrader, could...

In early March 2026, NTT DOCOMO, StarHub and ServiceNow announced a joint initiative to build an AI‑driven, autonomous roaming resolution model on the ServiceNow AI Platform, aiming to standardize and automate how carriers identify and fix international roaming issues for travelers. This collaboration is material because it seeks to cut manual support, improve reliability for roaming customers, and create a globally scalable, shared operational framework between mobile operators. Next, we’ll...

Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier. See our latest analysis for Bio-Techne. Despite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...

Gaztransport & Technigaz (GTT) recently received an order from HD Korea Shipbuilding & Offshore Engineering for the LNG tank design of a Sonangol-owned carrier, to be built at HD Hyundai Samho and equipped with GTT’s Mark III Flex membrane containment system for delivery in the second quarter of 2028. This contract highlights continued adoption of GTT’s containment technology by leading Korean yards and reinforces its role in upcoming LNG shipping projects. We’ll now examine how this new LNG...

Japan Airlines (TSE:9201) updated investors on 2 March 2026 by raising its earnings guidance, lifting dividend forecasts for the current fiscal year, and initiating work on a new growth strategy following a board meeting. See our latest analysis for Japan Airlines. Despite the raised earnings and dividend guidance, Japan Airlines’ 30 day share price return of 16.7% and year to date share price return decline of 12.2% suggest momentum has recently cooled, even though the 1 year total...

Siltronic (XTRA:WAF) is back in focus after reporting 2025 results that shifted from net income to a net loss, alongside slightly lower sales and the impact of a production line shutdown. See our latest analysis for Siltronic. Despite the 2025 net loss and guidance for a tougher 2026, Siltronic’s share price has moved higher. The 90 day share price return of 23.41% and 1 year total shareholder return of 25.37% suggest that momentum has recently strengthened even against weaker longer term...

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...

Shanghai Henlius Biotech (SEHK:2696) has drawn fresh attention after China’s National Medical Products Administration approved phase 1 trials for two solid tumour candidates, HLX316 and HLX3901, both backed by positive preclinical safety and efficacy data. See our latest analysis for Shanghai Henlius Biotech. The recent NMPA green light for HLX316 and HLX3901 comes as Shanghai Henlius Biotech’s share price sits at HK$67.95, with a 90 day share price return of 13.53% and a very large 3 year...

Genscript Biotech has reported its full-year 2025 results, with sales rising to US$959.53 million while the company moved from a prior-year net income of US$2.96 billion to a net loss of US$532.83 million, alongside higher basic and diluted losses per share. A key driver of this sharp swing in reported profitability is the absence of the previous year’s very large one-time unrealised gain from deconsolidation, which means the latest figures chiefly reflect the underlying operating profile...